Click on a filter below to refine your search. Remove a filter to broaden your search.
Use was more likely among unmarried or unpartnered adults and those consuming alcohol.
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
Agency’s action could widen access to the drug if more insurance companies decide to cover it
Baseline CRP, Clinical Disease Activity Index and glucocorticoid dose predict resistance to CDAI-low disease activity achievement.
Poorer outcomes were seen for 30-day sustained clinical response and 14-day initial cure rates.
Caps are associated with a reduction in insulin costs, mainly driven by patients enrolled in health savings accounts.
The findings seen among adults of all ages, especially those aged 85 years or older; the risk was highest in the first 28 days after initiation.
A reduction was noted in 24-hour systolic BP at 36 weeks with treatment at 5, 10 15 mg tirzepatide versus placebo.
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.